Business
VVT Med Inc. (Formerly DXI Capital Corp.) Completes Reverse Takeover of V.V.T. Med Ltd. and Exiteam Acquisition Corp
VVT Med Inc. (Formerly DXI Capital Corp.) Completes Reverse Takeover of V.V.T. Med Ltd. and Exiteam Acquisition
About this update from Vvt Med Inc.
[{"type":"text","content":"Toronto, Ontario--(Newsfile Corp. - July 22, 2025) - VVT Med Inc. (TSXV: DXI.H) (formerly DXI Capital Corp.) (the \"Company\") is pleased to announce that it has completed its previously announced acquisition of all of the outstanding securities of V.V.T. Med Ltd. (\"VVT\") and Exiteam Acquisition Corp. (\"EAC\") pursuant to the terms of a definitive agreement dated September 30, 2024 (the \"Transaction\"). Further details regarding the Transaction are available in the Company's Filing Statement dated May 15, 2025 and its news releases dated May 21, 2025, June 30, 2025 and July 16, 2025, which can be found under the Company's profile on SEDAR+ at www.sedarplus.ca.\"The completion of this transaction marks a pivotal moment for VVT Medical as we transition into the public markets and unlock new opportunities for growth,\" said Erez Tetro, Chief Executive Officer of VVT Med Inc. \"With our innovative, minimally invasive solutions for varicose vein treatment, we are poised to accelerate adoption in key global markets and deliver greater value to patients, physicians, and our shareholders. This milestone is not just a financial step forward-it is a validation of our vision to redefine vein care.\"In connection with the completion of the Transaction, the TSX Venture Exchange (the \"TSXV\") conditionally approved the listing of the Company's common shares (the \"Company Shares\") under the new ticker symbol \"VVTM\". The Company Shares are expected to commence trading on the TSXV on or about July 30, 2025. A further press release will be issued once trading has commenced. The Transaction constituted a reverse takeover of the Company by VVT pursuant to Policy 5.2 of the TSXV.The Transaction was completed according to the terms of a definitive agreement dated September 30, 2024 (the \"Definitive Agreement\") pursuant to which (i) the Company acquired all of the issued and outstanding securities of EAC by way of a three-cornered amalgamation with a wholly-owned subsidiary of the Company under the laws of the Province of British Columbia; and (ii) the Company acquired all of the issued and outstanding securities of VVT pursuant to a share exchange agreement entered into among the Company and each of VVT's securityholders. As consideration, each ordinary share of VVT (\"VVT Share\") was exchanged for Company Shares on the basis of...